A novel NCOR2-NTRK1 fusion detected in a patient of lung adenocarcinoma and response to larotrectinib: a case report

BACKGROUND: The identification of NTRK fusions in tumours has become critically important due to the actionable events predictive of response to TRK inhibitor. It is not clear whether the NTRK breakpoint location is different for response to targeted therapy and NTRK fusions affects the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Liu, Huanhuan, Tian, Ye, Wang, Huina, Yang, Xueying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052639/
https://www.ncbi.nlm.nih.gov/pubmed/33865348
http://dx.doi.org/10.1186/s12890-021-01490-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052639/
https://www.ncbi.nlm.nih.gov/pubmed/33865348
http://dx.doi.org/10.1186/s12890-021-01490-x

Ejemplares similares